Kymera Therapeutics, Inc. Common Stock KYMR
$117.39
+2.60%
at last close
Analyst Consensus
- Consensus Rating
- Buy (19 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $126.95
- Implied Upside
- +8.1%
- Price Target Range
- $100.00 – $155.00
- Analysts (12 mo)
- 22
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-06 | BarclaysEliana Merle |
Maintains | Overweight | $133 → $139 |
| 2026-07-30 | Deutsche BankDavid Hoang |
Initiates coverage on | Hold | $120 |
| 2026-07-28 | GuggenheimBrad Canino |
Maintains | Buy | $125 → $135 |
| 2026-07-16 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $120 → $140 |
| 2026-07-13 | RBC CapitalBrian Abrahams |
Downgrades | Outperform → Sector perform | $106 → $115 |
| 2026-06-30 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $110 → $125 |
| 2026-06-29 | Truist SecuritiesSrikripa Devarakonda |
Maintains | Buy | $116 → $136 |
| 2026-06-29 | B. Riley SecuritiesKalpit Patel |
Maintains | Buy | $117 → $155 |
| 2026-06-26 | Canaccord GenuityEdward Nash |
Maintains | Buy | $106 → $129 |
| 2026-06-25 | BTIGJeet Mukherjee |
Reiterates | Buy | $134 |
| 2026-05-06 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $106 |
| 2026-03-16 | JefferiesFaisal Khurshid |
Assumes | Buy | $122 → $110 |
| 2026-03-03 | UBSDavid Dai |
Maintains | Buy | $90 → $128 |
| 2026-03-02 | CitigroupGeoff Meacham |
Maintains | Buy | $110 → $120 |
| 2026-03-02 | Stephens & Co.Sudan Loganathan |
Maintains | Overweight | $95 → $100 |
| 2026-02-26 | BTIGJeet Mukherjee |
Maintains | Buy | $138 → $134 |
| 2026-02-26 | Piper SandlerBiren Amin |
Maintains | Overweight | $125 → $140 |
| 2026-02-03 | BTIGJeet Mukherjee |
Reiterates | Buy | $138 |
| 2026-01-28 | BarclaysEtzer Darout |
Maintains | Overweight | $119 → $133 |
| 2026-01-15 | BTIGJeet Mukherjee |
Reiterates | Buy | $138 |
| 2026-01-06 | Wolfe ResearchAndy Chen |
Downgrades | Outperform → Peer perform | — |
| 2025-12-22 | B. Riley SecuritiesKalpit Patel |
Maintains | Buy | $80 → $117 |
| 2025-12-16 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $70 → $103 |
| 2025-12-11 | Stephens & Co.Sudan Loganathan |
Maintains | Overweight | $65 → $110 |
| 2025-12-11 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $81 → $120 |
| 2025-12-10 | JP MorganBrian Cheng |
Maintains | Overweight | $70 → $125 |
| 2025-12-09 | JefferiesKelly Shi |
Maintains | Buy | $73 → $122 |
| 2025-12-09 | CitigroupGeoff Meacham |
Maintains | Buy | $80 → $110 |
| 2025-12-09 | Wells FargoDerek Archila |
Maintains | Overweight | $69 → $116 |
| 2025-12-09 | Truist SecuritiesSrikripa Devarakonda |
Maintains | Buy | $80 → $116 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $117.39
- Market Cap
- $9.48 billion
- 52-Week Range
- $36.65 – $130.05
- Average Volume
- 646K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.